Celestica (NYSE:CLS) Issues FY 2026 Earnings Guidance

Celestica (NYSE:CLS) (TSE:CLS) updated its FY 2026 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of 10.150-10.150 for the period, compared to the consensus estimate of 8.900. The company issued revenue guidance of $19.0 billion-$19.0 billion, compared to the consensus revenue estimate of $17.4 billion. Celestica also updated its Q2 2026 guidance to 2.140-2.340 EPS.

Celestica Price Performance

Shares of NYSE:CLS opened at $361.59 on Wednesday. The company’s fifty day moving average is $309.83 and its two-hundred day moving average is $307.90. The company has a market cap of $41.57 billion, a P/E ratio of 43.72, a price-to-earnings-growth ratio of 1.26 and a beta of 1.88. Celestica has a 12-month low of $81.88 and a 12-month high of $423.25. The company has a quick ratio of 0.88, a current ratio of 1.44 and a debt-to-equity ratio of 0.34.

Celestica (NYSE:CLS) (TSE:CLS) last issued its earnings results on Monday, April 27th. The technology company reported $2.16 EPS for the quarter, topping the consensus estimate of $2.08 by $0.08. The business had revenue of $3.96 billion during the quarter, compared to analysts’ expectations of $4.06 billion. Celestica had a return on equity of 37.35% and a net margin of 6.95%.Celestica’s revenue was up 52.8% compared to the same quarter last year. During the same quarter last year, the firm posted $1.20 earnings per share. Celestica has set its FY 2026 guidance at 10.150-10.150 EPS and its Q2 2026 guidance at 2.140-2.340 EPS. Equities analysts expect that Celestica will post 8.5 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several research firms have weighed in on CLS. Zacks Research cut Celestica from a “strong-buy” rating to a “hold” rating in a research note on Monday, April 6th. Canaccord Genuity Group raised their price target on shares of Celestica from $400.00 to $430.00 and gave the stock a “buy” rating in a report on Monday, February 2nd. TD Securities raised shares of Celestica from a “hold” rating to a “buy” rating and set a $430.00 price objective on the stock in a research report on Wednesday. Wolfe Research upgraded shares of Celestica to a “strong-buy” rating in a research note on Tuesday, February 17th. Finally, Citigroup reiterated a “buy” rating on shares of Celestica in a research report on Wednesday. One analyst has rated the stock with a Strong Buy rating, sixteen have assigned a Buy rating and four have assigned a Hold rating to the company’s stock. According to data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $400.50.

Insider Activity at Celestica

In other Celestica news, insider Yann L. Etienvre sold 86,229 shares of Celestica stock in a transaction that occurred on Monday, February 2nd. The shares were sold at an average price of $287.45, for a total value of $24,786,526.05. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, President Todd C. Cooper sold 89,484 shares of the firm’s stock in a transaction on Monday, February 2nd. The shares were sold at an average price of $287.45, for a total transaction of $25,722,175.80. Following the transaction, the president owned 108,970 shares in the company, valued at $31,323,426.50. This represents a 45.09% decrease in their position. The SEC filing for this sale provides additional information. Over the last quarter, insiders have sold 297,923 shares of company stock valued at $88,027,459. 1.10% of the stock is currently owned by corporate insiders.

Celestica News Roundup

Here are the key news stories impacting Celestica this week:

• Positive Sentiment: Q1 EPS beat and strong outlook: Celestica reported $2.16 EPS (above the $2.08 consensus) and raised FY2026 guidance to $19.0B revenue and $10.15 adj EPS — a material upgrade that confirms significant AI/cloud demand. Read More.
• Positive Sentiment: Cloud & AI (CCS) strength: CCS revenue jumped sharply and margins expanded, underpinning management’s bullish guidance and multi‑year AI infrastructure tailwinds. Read More.
• Neutral Sentiment: High‑quality guidance but already reflected: Q2 EPS guide of $2.14–2.34 and revenue guide $4.2B–$4.5B top consensus, yet investors may view the raises as confirmation of expectations rather than incremental surprise. Read More.
• Neutral Sentiment: Institutional interest in AI infrastructure: Celestica is being highlighted by some research/idea lists as an AI‑infrastructure play, supporting longer‑term demand visibility. Read More.
• Negative Sentiment: Revenue vs some sell‑side models: Q1 revenue was $3.96B versus some analyst estimates nearer $4.06B — EPS beat masked the top‑line shortfall for traders focused on scale and bookings. Read More.
• Negative Sentiment: Post‑earnings sell‑off / profit‑taking: Despite the beat and raised guide, shares dropped sharply after hours and into the next session as traders locked in gains and rotated out of a recent high‑momentum name. Read More.
• Negative Sentiment: Valuation and momentum fatigue concerns: Analysts/commentary warn CLS trades at a premium P/E vs. ODM peers and some view much of the growth narrative as priced in, which makes the stock vulnerable to short‑term rotation. Read More.
• Negative Sentiment: Analyst/market debate on expectations: Several outlets note investors “wanted more” despite a double beat, highlighting how elevated expectations can amplify downside after otherwise strong prints. Read More.

Institutional Trading of Celestica

A number of institutional investors and hedge funds have recently made changes to their positions in CLS. Viking Global Investors LP acquired a new position in shares of Celestica during the 3rd quarter valued at about $424,459,000. AQR Capital Management LLC bought a new stake in Celestica during the fourth quarter worth approximately $315,497,000. Price T Rowe Associates Inc. MD grew its holdings in Celestica by 79.9% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 687,349 shares of the technology company’s stock valued at $203,188,000 after purchasing an additional 305,265 shares during the last quarter. Marshall Wace LLP raised its position in shares of Celestica by 1,249.0% in the third quarter. Marshall Wace LLP now owns 278,928 shares of the technology company’s stock valued at $68,722,000 after purchasing an additional 258,251 shares during the period. Finally, Mackenzie Financial Corp raised its position in shares of Celestica by 126.8% in the fourth quarter. Mackenzie Financial Corp now owns 452,110 shares of the technology company’s stock valued at $135,080,000 after purchasing an additional 252,790 shares during the period. Institutional investors and hedge funds own 67.38% of the company’s stock.

About Celestica

Celestica Inc is a multinational electronics manufacturing services (EMS) company that provides design, engineering, manufacturing and supply chain solutions to original equipment manufacturers across a range of industries. Headquartered in Toronto, Ontario, Canada, Celestica works with customers to develop and produce complex electronic and electro-mechanical products, integrating activities from product design and prototyping through high-volume assembly, testing and final system integration.

The company’s service offering typically includes product engineering and design support, printed circuit board assembly, box-build and systems assembly, automated test and inspection, aftermarket repair and refurbishment, and end-to-end supply chain and logistics management.